Morvan's syndrome

Morvan's syndrome
SpecialtyNeurology Edit this on Wikidata
SymptomsSevere, barbiturate-refractory insomnia, agrypnia excitata, confusion, myoclonus, neuromyotonia, myokymia, autonomic failure, tachycardia, hyperhidrosis, constipation, arrhythmia, hallucinations, hyponatremia, weight loss
ComplicationsVentricular fibrillation, sudden cardiac arrest
Usual onsetVariable, usually between 37 and 66 years of age
CausesAnti-CASPR2 or LGI1 antibodies, usually, but not always, secondary to cancer
Risk factorsMale sex, cancer (usually a thymoma), Slavic heritage, various mutations
Diagnostic methodDetection of anti-CASPR2 or LGI1 antibodies in cerebrospinal fluid, symptoms and screening for cancer assists diagnosis
Differential diagnosisLimbic encephalitis, Isaacs syndrome, Guillain-Barre syndrome, myasthenia gravis, fatal insomnia, other autoimmune diseases
PreventionRegularly screening for cancer
TreatmentPlasma exchange, corticosteroids, treating the underlying cancer, if present
MedicationAzathioprine, rituximab, lacosamide
PrognosisVariable, recovery rates range from seven in eight to two in three
FrequencyUnknown, less than one in one million, probably underreported

Morvan's syndrome (also known as Morvan's fibrillary chorea or fibrillary chorea, abbreviated as MoS) is a rare, life-threatening autoimmune disease named after the nineteenth century French physician Augustin Marie Morvan. "La chorée fibrillaire" was coined by Morvan in 1890 when describing patients with multiple, irregular contractions of the long muscles, cramping, weakness, pruritus, hyperhidrosis, insomnia and delirium. It normally presents with a slow insidious onset over months to years..

In 1890, Morvan described a patient with myokymia (muscle twitching) associated with muscle pain, excessive sweating, and disordered sleep. This rare disorder is characterized by severe insomnia, amounting to no less than complete lack of sleep (agrypnia) for weeks or months in a row, and associated with autonomic alterations consisting of profuse perspiration with characteristic skin miliaria (also known as sweat rash), tachycardia, increased body temperature, and hypertension. Patients display a remarkable hallucinatory behavior, and peculiar motor disturbances, which Morvan reported under the term “fibrillary chorea” but which are best described in modern terms as neuromyotonic discharges.

The association of the disease with thymoma, tumour, autoimmune diseases, and autoantibodies suggests an autoimmune or paraneoplastic aetiology. Besides an immune-mediated etiology, it is also believed to occur in gold, mercury, or manganese poisoning.